V. Bronte, S. Brandau, S. Chen, M. P. Colombo, A. B. Frey et al., Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards, Nat Commun, vol.7, p.12150, 2016.

F. Uhel, I. Azzaoui, M. Grégoire, C. Pangault, J. Dulong et al., Early Expansion of Circulating Granulocytic Myeloid-derived Suppressor Cells Predicts Development of Nosocomial Infections in Patients with Sepsis, Am J Respir Crit Care Med, vol.196, pp.315-342, 2017.

I. Azzaoui, F. Uhel, D. Rossille, C. Pangault, J. Dulong et al., T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells, Blood, vol.128, pp.1081-92, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01394657

S. Lang, K. Bruderek, C. Kaspar, B. Höing, O. Kanaan et al., Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets, Clin Cancer Res, vol.24, pp.4834-4878, 2018.

V. Fleming, X. Hu, R. Weber, V. Nagibin, C. Groth et al., Targeting MyeloidDerived Suppressor Cells to Bypass Tumor-Induced Immunosuppression, Front Immunol, vol.9, pp.11-12, 2018.

K. Ok?a, A. Czerwonka, A. Wawruszak, M. Bobi?ski, M. Bilska et al., Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer, Front Immunol, vol.10, pp.394-407, 2019.